SCHEMBL2656956

SCHEMBL2656956

[CH2]c1ccc(NC(=O)c2cc(OCCc3ccsc3)cc(OC(C)C)c2)nc1

nearest known ligand 0.81

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
GCK P35557 20/20 0.81
RARA P10276 1/20 0.52
RARB P10826 1/20 0.52
RARG P13631 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2656697 0.89 GCK (0.81) GCKRARARARBRARG
SCHEMBL2657449 0.89 GCK (0.81) GCKRARARARBRARG
SCHEMBL14505791 0.89 GCK (1.00) GCKRARARARBRARG
SCHEMBL2657270 0.89 GCK (0.79) GCKRARARARBRARG
SCHEMBL16674411 0.88 GCK (0.78) GCKRARARARBRARG
SCHEMBL2664885 0.88 GCK (0.78) GCKRARARARBRARG
SCHEMBL2662202 0.87 GCK (0.77) GCKRARARARBRARG
SCHEMBL2669719 0.87 GCK (0.77) GCKRARARARBRARG
SCHEMBL12021286 0.86 GCK (0.76) GCKRARARARBRARG
Hydrochloric Acid SCHEMBL2656226 0.86 GCK (0.76) GCKRARARARBRARG

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2185570-A2 NOVEL ACTIVATORS OF GLUCOKINASE Metabasis Therapeutics, Inc. (US) 2010-05-19 EP disclosed
WO-2009023718-A2 NOVEL ACTIVATORS OF GLUCOKINASE METABASIS THERAPEUTICS, INC. (US) 2009-02-19 WO disclosed